Phenobarbital Pharmacokinetics and Optimal Dosing of Phenobarbital

Abstract

Researchers from the Baylor College of Medicine in Houston, TX, USA, conducted a retrospective population pharmacokinetic analysis of 355 patients ages less than 19 years of age in the inpatient setting who were initiated on intravenous or oral phenobarbital therapy and had one or more serum phenobarbital concentrations sampled.

Keywords

• epilepsy, phenobarbital, antiepileptic drugs